Zobrazeno 1 - 10
of 23
pro vyhledávání: '"T E, Sashenkova"'
Autor:
S. R. Allayarov, U. Yu. Allayarova, E. N. Klimanova, S. V. Demidov, T. E. Sashenkova, S. V. Blokhina, D. V. Mishchenko
Publikováno v:
High Energy Chemistry. 57:132-139
Autor:
T. N. Bogatyrenko, N. V. Kandalintseva, T. E. Sashenkova, U. Yu. Allayarova, D. V. Mishchenko
Publikováno v:
Russian Chemical Bulletin. 71:517-523
Autor:
Alexander V. Chernyak, T. E. Sashenkova, E. N. Klimanova, D. V. Mishchenko, Yu. R. Aleksandrova, Margarita E. Neganova, I. V. Vystorop, Gennady V. Shilov, U. Yu. Allayarova, Sergey G. Klochkov
Publikováno v:
Russian Journal of Bioorganic Chemistry. 47:757-764
The reaction of DL-valine hydroxamic acid with triacetonamine proceeds as the N,N'-regioselective condensation to form (±)-1-hydroxy-3-isopropyl-7,7,9,9-tetramethyl-1,4,8-triazaspiro[4,5]decan-2-one. A study of the antimetastatic and antitumor activ
Autor:
Sergey G. Klochkov, Margarita E. Neganova, Ghulam Md Ashraf, George E. Barreto, T. E. Sashenkova, Gjumrakch Aliev, Nagendra Sastry Yarla, E. N. Klimanova, Vadim V. Tarasov, I. V. Vystorop, Anna N. Samsonova, D. V. Mishchenko, Vladimir N. Chubarev, Elena F. Shevtsova
Publikováno v:
Current Cancer Drug Targets. 18:365-371
Background: Anti-tumor effect of hydroxamic acid derivatives is largely connected with its properties as efficient inhibitors of histone deacetylases, and other metalloenzymes involved in carcinogenesis. Objective: The work was aimed to (i) determine
Publikováno v:
Russian Chemical Bulletin. 67:700-704
Due to the multifactorial nature of cancer diseases, investigations of combinations of the known cytostatics with substances that are chemosensitizers and act on various molecular target in the organism gain increasing significance. Polyfunctional co
Autor:
Nurgali Akylbekov, Julia K. Voronina, Anastasiya V. Gildebrant, T. E. Sashenkova, A. A. Balakina, Ugulzhan Allayarova, A. R. Burilov, Andrey V. Smolobochkin, I. S. Sazykin, Anastasia S. Sapunova, E. N. Klimanova, Elena Chugunova, D. V. Mishchenko, Alexandra D. Voloshina, Maria Klimova, Almir S. Gazizov, M. A. Sazykina, Shorena Karchava
Publikováno v:
Molecules
Volume 24
Issue 17
Molecules, Vol 24, Iss 17, p 3086 (2019)
Volume 24
Issue 17
Molecules, Vol 24, Iss 17, p 3086 (2019)
A library of novel 2-(het)arylpyrrolidine-1-carboxamides were obtained via a modular approach based on the intramolecular cyclization/Mannich-type reaction of N-(4,4-diethoxybutyl)ureas. Their anti-cancer activities both in vitro and in vivo were tes
Publikováno v:
AIP Conference Proceedings.
The reaction of DL-valine hydroxamic acid with triacetonamine passes as N, N′-regioselective cyclocondensation to form (±) -1-hydroxy-3-isopropyl-7,7,9,9-tetramethyl-1,4,8-triazaspiro [4.5] decan-2-one. In vivo study of chemosensitizing antitumor
Autor:
D. V. Mishchenko, A. B. Eremeev, G. N. Bogdanov, L. V. Tat’yanenko, Fedorov Boris S, T. E. Sashenkova, Nina P. Konovalova, Mikhail A. Fadeev
Publikováno v:
Russian Chemical Bulletin. 65:801-805
Monoand disubstituted N-hydroxyamides of dicarboxylic acids were prepared by reaction of dicarboxylic acids or acid anhydrides with hydroxylamine. The use of these compounds in combinatorial cytostatic therapy of implanted tumors with cisplatin or cy
Autor:
T. E. Sashenkova, Nina P. Konovalova, V. R. Bogatyrenko, T. N. Bogatyrenko, Z. V. Kuropteva, D. V. Mishchenko, L. M. Bayder
Publikováno v:
Russian Chemical Bulletin. 65:561-565
The present investigation is based on the paradoxical dichotomy of the biological action of nitric oxide (NO). Depending on its concentration in the organism, it can have therapeutic or pathogenic effect. It was shown that during the treatment with c
Polyfunctional action of biologically active compounds in antitumor chemotherapy of cyclophosphamide
Autor:
T. E. Sashenkova, Z. V. Kuropteva, A. M. Sipyagin, Nina P. Konovalova, V. R. Bogatyrenko, T. N. Bogatyrenko, L. M. Baider, Fedorov Boris S
Publikováno v:
Russian Chemical Bulletin. 63:1187-1191
Combinations of the known cytostatic cyclophosphamide (cyclophosphan) with hydroxamic acids (asparagylhydroxamic and salicylhydroxamic), nitric oxide donor (sodium nitrate), and an original hybrid non-steroidal anti-inflammatory compound, viz., diclo